<DOC>
	<DOC>NCT00466440</DOC>
	<brief_summary>The purpose of the study is to compare the response rates for prostate cancer patients taking chemotherapy plus enzastaurin versus chemotherapy plus placebo.</brief_summary>
	<brief_title>A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>You are at least 18 years old. You live close enough to the doctor's office to attend all of your required visits. You have not been treated with chemotherapy for your prostate cancer. Your organs must be functioning properly. You are unable to swallow pills. You have another serious illness besides your prostate cancer. You have taken another experimental drug within the last 30 days. You have a serious heart condition. You are receiving another anticancer therapy.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>